18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy

Marina Hodolic; Raffi Topakian; Robert Pichler

doi:10.1515/raon-2016-0032

Abstract

Background

Epilepsy is a neurological disorder characterized by epileptic seizures as a result of excessive neuronal activity in the brain. Approximately 65 million people worldwide suffer from epilepsy; 20–40% of them are refractory to medication therapy. Early detection of disease is crucial in the management of patients with epilepsy. Correct localization of the ictal onset zone is associated with a better surgical outcome. The modern non-invasive techniques used for structural-functional localization of the seizure focus includes electroencephalography (EEG) monitoring, magnetic resonance imaging (MRI), single photon emission tomography/computed tomography (SPECT/CT) and positron emission tomography/computed tomography (PET/CT). PET/CT can predict surgical outcome in patients with refractory epilepsy. The aim of the article is to review the current role of routinely used tracer 2-deoxy-2-[¹⁸F]fluoro-D-glucose (¹⁸F-FDG) as well as non routinely used ¹⁸F-Flumazenil (¹⁸F-FMZ) tracers PET/CT in patients with refractory epilepsy.

Conclusions

Functional information delivered by PET and the morphologic information delivered by CT or MRI are essential in presurgical evaluation of epilepsy. Nowadays ¹⁸F-FDG PET/CT is a routinely performed imaging modality in localization of the ictal onset zone in patients with refractory epilepsy who are unresponsive to medication therapy. Unfortunately, ¹⁸F-FDG is not an ideal PET tracer regarding the management of patients with epilepsy: areas of glucose hypometabolism do not correlate precisely with the proven degree of change within hippocampal sclerosis, as observed by histopathology or MRI. Benzodiazepine-receptor imaging is a promising alternative in nuclear medicine imaging of epileptogenic focus. The use of ¹¹C-FMZ in clinical practice has been limited by its short half-life and necessitating an on-site cyclotron for production. Therefore, ¹⁸F-FMZ might be established as one of the tracers of choice for patients with refractory epilepsy because of better sensitivity and anatomical resolution.

References

National Institute for Health and Clinical Excellence. Chapter 1. Introduction. In: National Clinical Guideline Centre, editors. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London: Royal College of Physicians (UK); 2012. p. 21-8.
Search in Google Scholar Back to article
Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, et al. ILAE commission on epidemiology. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011; 52(Suppl 7): 2-26.
Search in Google Scholar Back to article
Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-9.
Search in Google Scholar Back to article
Kelly KM, Chung SS. Surgical treatment for refractory epilepsy: review of patient evaluation and surgical options. Epilepsy Res Treat 2011; 2011:303624.
Search in Google Scholar Back to article
Chou CC, Shih YH, Yen DJ, Kwan SY, Yu HY. Long-term health-related quality of life in drug-resistant temporal lobe epilepsy after anterior temporal lobectomy. Epileptic Disord 2015; 17: 177-83.
Search in Google Scholar Back to article
Gomez-Alonso J, Bellas-Lamas P. Surgical treatment for drug-resistant epilepsy. JAMA 2015; 313:1572.
Search in Google Scholar Back to article
Liu SY, Yang XL, Chen B, Hou Z, An N, Yang MH, et al. Clinical outcomes and quality of life following surgical treatment for refractory epilepsy: a systematic review and meta-analysis. Medicine (Baltimore) 2015; 94: e500.
Search in Google Scholar Back to article
Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomised, controlled trial of surgery for temporal lobe epilepsy. N Engl J Med 2001; 345: 365-7.
Search in Google Scholar Back to article
Taft C, Sager Magnusson E, Ekstedt G, Malmgren K. Health-related quality of life, mood, and patient satisfaction after epilepsy surgery in Sweden-a prospective controlled observational study. Epilepsia 2014; 55: 878-85.
Search in Google Scholar Back to article
Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003; 60: 538-47.
Search in Google Scholar Back to article
Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. Lancet Neurol 2014; 13: 1114-26.
Search in Google Scholar Back to article
Lehericy S, Semah F, Hasboun D, Dormont D, Clemenceau S, Granat O, et al. Temporal lobe epilepsy with varying severity: MRI study of 222 patients. Neuroradiology 1997; 39: 788-96.
Search in Google Scholar Back to article
Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS. The utility of ¹⁸F fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res 2014; 108:1306-14.
Search in Google Scholar Back to article
Devous M, Thisted R, Morgan G, Leroy R, Rowe C. SPECT brain imaging in epilepsy: a meta-analysis. J Nucl Med 1998; 39: 285-93.
Search in Google Scholar Back to article
Spencer S. The relative contributions of MRI, SPECT and PET imaging in epilepsy. Epilepsia 1994; 35: S72-89.
Search in Google Scholar Back to article
Weil S, Noachtar S, Arnold S, Yousry TA, Winkler PA, Tatsch K. Ictal ECDSPECT differentiate between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control. Nucl Med Commun 2001; 22: 233-7.
Search in Google Scholar Back to article
Blum DE, Ehsan T, Dungan D, Karis JP, Fisher RS. Bilateral temporal hypometabolism in epilepsy. Epilepsia 1998; 39: 651-9.
Search in Google Scholar Back to article
Willmann O, Wennberg R, May T, Woermann FG, Pohlmann-Eden B. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy. A meta-analysis. Seizure 2007; 16: 509-20.
Search in Google Scholar Back to article
Taft C, Sager Magnusson E, Ekstedt G, Malmgren K. Health-related quality of life, mood, and patient satisfaction after epilepsy surgery in Sweden-a prospective controlled observational study. Epilepsia 2014; 55: 878-85.
Search in Google Scholar Back to article
Swartz BE, Tomiyasu U, Delgado-Escueta AV, Mandelkern M, Khonsari A. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and post-surgical outcome. Epilepsia 1992; 33: 624-34.
Search in Google Scholar Back to article
Manno EM, Sperling MR, Ding X, Jaggi J, Alavi A, O’Connor MJ, et al. Predictors of outcome after anterior temporal lobectomy: Positron emission tomography. Neurology 1994; 44: 2331-6.
Search in Google Scholar Back to article
Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: The role of positron emission tomography. Ann Neurol 1992; 32: 789-94.
Search in Google Scholar Back to article
Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS. The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res 2014; 108: 1306-14.
Search in Google Scholar Back to article
Singhal T, Alavi A, Kim CK. Brain: positron emission tomography tracers beyond [¹⁸F]fluorodeoxyglucose. PET Clin 2014; 9: 267-76.
Search in Google Scholar Back to article
Inaji M, Maehara T. PET, SPECT, and MEG in the diagnosis of epilepsy. Nihon Rinsho 2014; 72: 827-33.
Search in Google Scholar Back to article
Casse R, Rowe CC, Newton M, Berlangieri SU, Scott AM. Positron emission tomography and epilepsy. Mol Imaging Biol 2002; 4: 338-51.
Search in Google Scholar Back to article
Ismet Sarikaya. PET studies in epilepsy. Am J Nucl Med Mol Imaging 2015; 5: 416-30.
Search in Google Scholar Back to article
Kuhl E, Engel J, Phelps E, Selin C. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980; 18: 348-60.
Search in Google Scholar Back to article
Engel, J, Kuhl E, Phelps E, Crandall H. Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 198; 12: 529-37.
Search in Google Scholar Back to article
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging 2009; 36: 2103-10.
Search in Google Scholar Back to article
Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17: 302-16.
Search in Google Scholar Back to article
Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 1995; 36: 1141-9.
Search in Google Scholar Back to article
Won HJ, Chang KH, Cheon JE, Kim HD, Lee DS, Han MH, et al. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR Am J Neuroradiol 1999; 20: 593-9.
Search in Google Scholar Back to article
Hwang SI, Kim JH, Park SW, Han MH, Yu IK, Lee SH, et al. Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy. Am J Neuroradiol 2001; 22: 937-46.
Search in Google Scholar Back to article
Fink GR, Pawlik G, Stefan H, Pietrzyk U, Wienhard K, Heiss WD. Temporal lobe epilepsy: evidence for interictal uncoupling of blood flow and glucose metabolism in temporomesi al structures. J Neurol Sci 1996; 137: 28-34.
Search in Google Scholar Back to article
Zubal IG, Avery RA, Stokking R, Studholme C, Corsi M, Dey H, et al. Ratio-images calculated from interictal positron emission tomography and single-photon emission computed tomography for quantification of the uncoupling of brain metabolism and perfusion in epilepsy. Epilepsia 2000; 41:1560-6.
Search in Google Scholar Back to article
Buch K, Blumenfeld H, Spencer S, Novotny E, Zubal IG. Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization. Eur J Nucl Med Mol Imaging 2008; 35: 579-88.
Search in Google Scholar Back to article
Desai A, Bekelis K, Thadani VM, Roberts DW, Jobst BC, Duhaime AC, et al. Interictal PET and ictal subtraction SPECT: sensitivity in the detection of seizure foci in patients with medically intractable epilepsy. Epilepsia 2013; 54: 341-50.
Search in Google Scholar Back to article
Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, et al. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med 1999; 40: 737-46.
Search in Google Scholar Back to article
Javeria N, Rajesh I, Seetharam R. Ictal PET in presurgical workup of refractory extratemporal epilepsy. Ann Indian Acad Neurol 2013; 16: 676-7.
Search in Google Scholar Back to article
Siclari F, Prior JO, Rossetti AO. Ictal cerebral positron emission tomography (PET) in focal status epilepticus. Epilepsy Res 2013; 105: 356-61.
Search in Google Scholar Back to article
Engel J Jr, Brown WJ, Kuhl DE, Phelps ME, Mazziotta JC, Crandall PH. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 1982; 12: 518-28.
Search in Google Scholar Back to article
Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 2002; 213: 1-47.
Search in Google Scholar Back to article
Sieghart W. Pharmacology of benzodiazepine receptors: an update. J Psychiatry Neurosci 1994; 19: 24-9.
Search in Google Scholar Back to article
Derry JM, Dunn SM, Davies M. Identification of a residue in the gammaaminobutyric acid type A receptor alpha subunit that differentially affects diazepam-sensitive and -insensitive benzodiazepine site binding. J Neurochem 2004; 88: 1431-8.
Search in Google Scholar Back to article
Goldfrank, Lewis R. Goldfrank’s toxicologic emergencies. New York: McGraw-Hill; 2002.
Search in Google Scholar Back to article
Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988; 2: 863-6.
Search in Google Scholar Back to article
Heiss WD, Kracht L, Grond M, Rudolf J, Bauer B, Wienhard K, et al. [(11) C]Flumazenil/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 2000; 31: 366-9.
Search in Google Scholar Back to article
Mayer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer´s disease. Arch Neuro 1995; 52: 314-7.
Search in Google Scholar Back to article
Pascual B, Prieto E, Arbizu J, Marti-Climent JM, Peñuelas I, Quincoces G, et al . Decreased carbon-11-flumazenil binding in early Alzheimer’s disease. Brain 2012; 135: 2817-25.
Search in Google Scholar Back to article
Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C, et al. PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiatry Res 1993; 50:1-13.
Search in Google Scholar Back to article
Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992; 12: 924-9.
Search in Google Scholar Back to article
Maziere M, Hantraye P, Prenant C, Sastre J, Comar D. Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo [1,5-a] [1,4]benzodiazepine-3-carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isot 1984; 35: 973-6.
Search in Google Scholar Back to article
Savic I, Ingvar M, Stone-Elander S. Comparison of [11C]flumazenil and [18F] FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993; 56: 615-21.
Search in Google Scholar Back to article
Boundy KL, Rowe CC, Black AB, Kitchener MI, Barnden LR, Sebben R, et al. Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography. Neurology 1996; 47: 1015-20.
Search in Google Scholar Back to article
Beer HF, Bläuenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al. In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 1990; 31: 1007-14.
Search in Google Scholar Back to article
Samson Y, Hantraye P, Baron JC, Soussaline F, Comar D, Mazière M. Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. Eur J Pharmacol 1985; 110: 247-51.
Search in Google Scholar Back to article
Moerlein SM, Perlmutter JS. Binding of 5-(2’-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography. Eur J Pharmacol 1992; 218: 109-15.
Search in Google Scholar Back to article
Leveque P, Labar D, Gallez B. Biodistribution, binding specificity and metabolism of [18F]fluoroethylflumazenil in rodents. Nucl Med Biol 2001; 28:809-14.
Search in Google Scholar Back to article
Grunder G, Siessmeier T, Lange-Asschenfeldt C, Vernaleken I, Buchholz HG, Stoeter P, et al. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors. Eur J Nucl Med 2001; 28: 1463-70.
Search in Google Scholar Back to article
Mitterhauser M, Wadsak W, Wabnegger L, Mien L-K, Togel S, Langer O, et al. Biological evaluation of 2ʹ-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET. Nucl Med Biol 2004; 31: 291-5.
Search in Google Scholar Back to article
Chang YS, Jeong JM, Yoon YH, Kang WJ, Lee SJ, Lee DS, et al. Biological properties of 2ʹ-[18F]fluoroflumazenil for central benzodiazepine receptor imaging. Nucl Med Biol 2005; 32: 263-8.
Search in Google Scholar Back to article
Ryzhikov NN, SenecaN, Krasikova RN, GomzinaNA, Shchukin E, Fedorova OS, et al. Preparation of highly specific radioactivity [18F] flumazenil and its evaluation in cynomolgus monkey by positron emission tomography. Nucl Med Biol 2005; 32: 109-16.
Search in Google Scholar Back to article
Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, et al. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. J Nucl Med 2013; 54:1270-7.
Search in Google Scholar Back to article

18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy

Abstract

Background

Conclusions

Paradigm

My account